- Home
- NMTC vs ATRA Comparison
NMTC vs ATRA Comparison
Compare NMTC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- ATRA
- Stock Information
- Founded
- NMTC 2009
- ATRA 2012
- Country
- NMTC United States
- ATRA United States
- Employees
- NMTC N/A
- ATRA N/A
- Industry
- NMTC Medical/Dental Instruments
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMTC Health Care
- ATRA Health Care
- Exchange
- NMTC Nasdaq
- ATRA Nasdaq
- Market Cap
- NMTC 33.8M
- ATRA 40.1M
- IPO Year
- NMTC N/A
- ATRA 2014
- Fundamental
- Price
- NMTC $0.72
- ATRA $9.22
- Analyst Decision
- NMTC Strong Buy
- ATRA Buy
- Analyst Count
- NMTC 1
- ATRA 5
- Target Price
- NMTC $1.45
- ATRA $17.75
- AVG Volume (30 Days)
- NMTC 178.3K
- ATRA 36.6K
- Earning Date
- NMTC 08-13-2025
- ATRA 08-11-2025
- Dividend Yield
- NMTC N/A
- ATRA N/A
- EPS Growth
- NMTC N/A
- ATRA N/A
- EPS
- NMTC N/A
- ATRA N/A
- Revenue
- NMTC $5,758,777.00
- ATRA $199,732,000.00
- Revenue This Year
- NMTC $141.04
- ATRA N/A
- Revenue Next Year
- NMTC $38.86
- ATRA N/A
- P/E Ratio
- NMTC N/A
- ATRA N/A
- Revenue Growth
- NMTC 54.53
- ATRA 475.53
- 52 Week Low
- NMTC $0.40
- ATRA $5.01
- 52 Week High
- NMTC $1.39
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- NMTC 63.09
- ATRA 68.21
- Support Level
- NMTC $0.68
- ATRA $7.54
- Resistance Level
- NMTC $0.77
- ATRA $8.25
- Average True Range (ATR)
- NMTC 0.05
- ATRA 0.46
- MACD
- NMTC 0.01
- ATRA 0.09
- Stochastic Oscillator
- NMTC 73.64
- ATRA 96.01
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).